March, 11 2014, 11:37am EDT
For Immediate Release
Contact:
Paul Towers, Pesticide Action Network: 916.216.1082; ptowers@panna.org
Lisa Griffith, National Family Farm Coalition, 202-543-5675; lisa@nffc.net
Anna Ghosh, Food and Water Watch: 415.293.9905; aghosh@fwwatch.org
Abigail Seiler, Center for Food Safety: 443.854.4368; aseiler@centerforfoodsafety.org
Farmers Warn of Threats to Farm Economies Posed by Dow's New Genetically Engineered Corn and Soybean Varieties
Today over 387,000 farmers, farmworkers, health professionals, and concerned individuals from across the country joined together in urging the U.S. Department of Agriculture (USDA) to reject Dow AgroSciences' application seeking approval of controversial genetically engineered (GE) corn and soybean varieties that are resistant to the hazardous herbicide 2,4-D.
WASHINGTON
Today over 387,000 farmers, farmworkers, health professionals, and concerned individuals from across the country joined together in urging the U.S. Department of Agriculture (USDA) to reject Dow AgroSciences' application seeking approval of controversial genetically engineered (GE) corn and soybean varieties that are resistant to the hazardous herbicide 2,4-D.
In addition, over 800 farmers from across the country petitioned Agriculture Secretary Vilsack to reject the pesticide-promoting seeds, warning that their introduction would directly harm their crops, farm businesses, livelihoods and health. The comments were submitted Tuesday, March 11, the last day of USDA's public comment period on its draft Environmental Impact Statement (EIS), a report that was supposed to assess possible harms associated with release of the new seed varieties. Thousands of additional comments critical of the GE seeds are expected to be submitted by the midnight deadline.
As USDA itself concedes, approval of 2,4-D-resistant corn and soybeans would lead to an unprecedented 200% to nearly 600% increase in agricultural use of 2,4-D by 2020, from 26 million to as much as 176 million lbs. per year. Independent scientists have projected far greater increases in corn alone. Even at current use levels, 2,4-D drift is responsible for more episodes of crop injury than any other herbicide.
"Farmers are on the front lines of this potential chemical disaster," said Lisa Griffith of the National Family Farm Coalition. "Losing crops means they lose wages, seeds for future plantings and markets, which also stresses their communities."
Karri Stroh, Executive Director of the Northern Plains Sustainable Agriculture Society explains, "Our farmer members raise a variety of certified crops, including organic soybeans, fruit and vegetables, that are highly sensitive to 2,4-D. If Dow's new 2,4-D seeds are approved and planted, and 2,4-D use surges across the country, those crops and the markets that depend on them will suffer tremendous losses. Those of us who live in farm country know that drift happens."
Texas-based Farm and Ranch Freedom Alliance leader, Judith McGeary, added, "With its rich diversity of farms, Texas agriculture is particularly at risk. Our farmers have orchards, vineyards, and produce farms in close proximity to row crop operations. The high volatility of 2,4-D, especially of the older, still widely available formulations, means that all of these farmers are at risk."
Critics point out that the main beneficiaries of the pesticide-promoting seeds are the pesticide manufacturers. "The new GE herbicide-resistant seeds are part of a technology package explicitly designed to facilitate increased, indiscriminate herbicide use and pump up chemical sales," explained Marcia Ishii-Eiteman, senior scientist at Pesticide Action Network. "These GE seeds are the growth engine of the pesticide industry's marketing strategy. That's why Dow itself describes weed resistance to herbicides as a 'great opportunity for chemical companies.'"
"Dow Chemical's 2,4-D resistant crops are bad for the farmer, the environment and the consumer. If approved, these pesticide-promoting crops will lead to millions of more pounds of this toxic pesticide contaminating our farms, our water, our air and our food. They will not solve our superweed problem, only spur the evolution of yet more herbicide-resistant weeds," said Andrew Kimbrell, executive director for Center for Food Safety.
The health of rural communities, especially children, is also at stake. 70 medical and public health professionals submitted a letter to USDA in 2012 warning of the severe health harms to rural communities that would likely accompany the expected massive increase in 2,4-D use.
"Many studies show that 2,4 D exposure is associated with various forms of cancer, Parkinson's disease, hormone disruption and birth defects. Children are especially susceptible," said Wenonah Hauter, executive director of Food & Water Watch. "USDA must take these significant risks seriously and reject approval of this crop."
"Secretary Vilsack has repeatedly stated his commitment to family farmers, rural communities and the revitalization of our local food systems. Rejecting Dow's 2,4-D seeds is the most important step he can take today to support our farmers and accomplish this aim," said Margot McMillen, Missouri farmer, member of the Executive Council to the National Family Farm Coalition and a victim of 2,4-D drift.
Groups submitting public comments to USDA include the Center for Food Safety, Farm and Ranch Freedom Alliance, Food & Water Watch, National Family Farm Coalition, National Organic Coalition, Organic Consumer Alliance, Organic Seed Alliance and Pesticide Action Network.
PANNA (Pesticide Action Network North America) works to replace pesticide use with ecologically sound and socially just alternatives. As one of five autonomous PAN Regional Centers worldwide, we link local and international consumer, labor, health, environment and agriculture groups into an international citizens' action network. This network challenges the global proliferation of pesticides, defends basic rights to health and environmental quality, and works to ensure the transition to a just and viable society.
LATEST NEWS
Senate Tosses 'Dangerous Provision' Preventing State-Level AI Regulation From GOP Megabill
"From the start, this provision had Big Tech's money and lobbyists all over it. This is a major victory for the American people over the AI industry," said one advocate.
Jul 01, 2025
With a 99-1 vote early Tuesday, the Republican-controlled Senate decided to remove a controversial provision that would have prevented state-level regulation on artificial intelligence for 10 years from U.S. President Donald Trump's massive tax and spending bill that is currently being debated in Congress.
Sen. Thom Tillis (R-N.C.) was the lone lawmaker who voted to keep the moratorium in the bill.
While far from the only controversial part of the reconciliation package, the provision drew opposition from an ideologically diverse group that included Democratic and Republican state attorneys general; over 140 groups working to support children's online safety, consumer protections, and responsible innovation; and faith leaders.
Senators struck Sen. Ted Cruz's (R-Texas) AI measure from the megabill by adopting an amendment introduced by Sen. Marsha Blackburn (R-Tenn.). They voted on Blackburn's amendment during a session known as a vote-a-rama. Blackburn introduced the amendment after considering an agreement that would have watered down the provision.
According to The Verge, the measure that was rejected on Tuesday required states to avoid regulation AI and "automated decision systems" if they wanted to get funding for their broadband programs.
The provision would have been a major win for Big Tech, which has made the case that state laws around AI are obstructing their ability to do business.
Advocates and Democratic lawmakers cheered the decision to strip the provision.
"From the start, this provision had Big Tech's money and lobbyists all over it. This is a major victory for the American people over the AI industry. It shows that Americans are aware of the proliferation of AI harms in real time," said J.B. Branch, Big Tech accountability advocate at the watchdog group Public Citizen.
Sen. Edward Markey (D-Mass.) said Tuesday that "early this morning, the Senate overwhelmingly voted to reject a dangerous provision to block states from regulating artificial intelligence, including protecting kids online. This 99-1 vote sent a clear message that Congress will not sell out our kids and local communities in order to pad the pockets of Big Tech billionaires."
In addition to concerns focused on Big Tech, experts recently told The Guardian that in the absence of state-level AI regulation, untrammeled growth of AI would take a toll on the world's "dangerously overheating climate."
Sacha Haworth, the executive director of the Tech Oversight Project, credited the "massive" defeat of Cruz's provision to the "incredible mobilizing by advocates to beat back Big Tech lobbying and last-minute bullying."
Keep ReadingShow Less
Critics Shred JD Vance as He Shrugs Off Millions of Americans Losing Medicaid as 'Minutiae'
"What happened to you J.D. Vance—author of Hillbilly Elegy—now shrugging off Medicaid cuts that will close rural hospitals and kick millions off healthcare as 'minutiae?'" asked Rep. Ro Khanna (D-Calif.).
Jul 01, 2025
Vice President J.D. Vance took heat from critics this week when he downplayed legislation that would result in millions of Americans losing Medicaid coverage as mere "minutiae."
Writing on X, Vance defended the budget megabill that's currently being pushed through the United States Senate by arguing that it will massively increase funding to Immigration and Customs Enforcement, which he deemed to be a necessary component of carrying out the Trump administration's mass deportation operation.
"The thing that will bankrupt this country more than any other policy is flooding the country with illegal immigration and then giving those migrants generous benefits," wrote Vance. "The [One Big Beautiful Bill] fixes this problem. And therefore it must pass."
He then added that "everything else—the CBO score, the proper baseline, the minutiae of the Medicaid policy—is immaterial compared to the ICE money and immigration enforcement provisions."
It was this line that drew the ire of many critics, as the Congressional Budget Office has estimated that the Senate version of the budget bill would slash spending on Medicaid and the Children's Health Insurance Program by more than $1 trillion over a ten-year-period, which would result in more than 10 million people losing their coverage. Additionally, Sen. Rick Scott (R-Fla.) has proposed an amendment that would roll back the expansion of Medicaid under the 2010 Affordable Care Act, which would likely kick millions more off of the program.
Many congressional Democrats were quick to pounce on Vance for what they said were callous comments about a vital government program.
"So if the only thing that matters is immigration... why didn't you support the bipartisan Lankford-Murphy bill that tackled immigration far better than your Ugly Bill?" asked Rep. Daniel Goldman (D-N.Y.). "And it didn't have 'minutiae' that will kick 12m+ Americans off healthcare or raise the debt by $4tn."
"What happened to you J.D. Vance—author of Hillbilly Elegy—now shrugging off Medicaid cuts that will close rural hospitals and kick millions off healthcare as 'minutiae?'" asked Rep. Ro Khanna (D-Calif.).
Veteran healthcare reporter Jonathan Cohn put some numbers behind the policies that are being minimized by the vice president.
"11.8M projected to lose health insurance," he wrote. "Clinics and hospitals taking a hit, especially in rural areas. Low-income seniors facing higher costs. 'Minutiae.'"
Activist Leah Greenberg, the co-chair of progressive organizing group Indivisible, zeroed in on Vance's emphasis on ramping up ICE's funding as particularly problematic.
"They are just coming right out and saying they want an exponential increase in $$$ so they can build their own personal Gestapo," she warned.
Washington Post global affairs columnist Ishaan Tharoor also found himself disturbed by the sheer size of the funding increase for ICE that Vance is demanding and he observed that "nothing matters more apparently than giving ICE a bigger budget than the militaries of virtually every European country."
Keep ReadingShow Less
'Heinrich Should Be Ashamed': Lone Senate Dem Helps GOP Deliver Big Pharma Win
The provision, part of the Senate budget bill, was described as "a blatant giveaway to the pharmaceutical industry that would keep drug prices high for patients while draining $5 billion in taxpayer dollars."
Jul 01, 2025
The deep-pocketed and powerful pharmaceutical industry notched a significant victory on Monday when the Senate parliamentarian ruled that a bill described by critics as a handout to drug corporations can be included in the Republican reconciliation package, which could become law as soon as this week.
The legislation, titled the Optimizing Research Progress Hope and New (ORPHAN) Cures Act, would exempt drugs that treat more than one rare disease from Medicare's drug-price negotiation program, allowing pharmaceutical companies to charge exorbitant prices for life-saving medications in a purported effort to encourage innovation. (Medications developed to treat rare diseases are known as "orphan drugs.")
The consumer advocacy group Public Citizen observed that if the legislation were already in effect, Medicare "would have been barred from negotiating lower prices for important treatments like cancer drugs Imbruvica, Calquence, and Pomalyst."
Among the bill's leading supporters is Sen. Martin Heinrich (D-N.M.), whose spokesperson announced the parliamentarian's decision to allow the measure in the reconciliation package after previously advising that it be excluded. Heinrich is listed as the legislation's only co-sponsor in the Senate, alongside lead sponsor Sen. John Barrasso (R-Wyo.).
"Sen. Heinrich should be ashamed of prioritizing drug corporation profits over lower medicine prices for seniors and people with disabilities," Steve Knievel, access to medicines advocate at Public Citizen, said in a statement Monday. "Patients and consumers breathed a sigh of relief when the Senate parliamentarian stripped the proposal from Republicans' Big Ugly Betrayal, so it comes as a gut punch to hear that Sen. Heinrich welcomed the reversal and continued to champion a proposal that will transfer billions from taxpayers to Big Pharma."
"People across the country are demanding lower drug prices and for Medicare drug price negotiations to be expanded, not restricted," Knievel added. "Sen. Heinrich should apologize to his constituents and start listening to them instead of drug corporation lobbyists."
The Biotechnology Innovation Organization, a lobbying group whose members include pharmaceutical companies, has publicly endorsed and promoted the legislation, urging lawmakers to pass it "as soon as possible."
"This is a blatant giveaway to the pharmaceutical industry that would keep drug prices high for patients."
The nonpartisan Congressional Budget Office has estimated that the ORPHAN Cures Act would cost U.S. taxpayers around $5 billion over the next decade.
Merith Basey, executive director of Patients For Affordable Drugs Now, said that "patients are infuriated to see the Senate cave to Big Pharma by reviving the ORPHAN Cures Act at the eleventh hour."
"This is a blatant giveaway to the pharmaceutical industry that would keep drug prices high for patients while draining $5 billion in taxpayer dollars," said Basey. "We call on lawmakers to remove this unnecessary provision immediately and stand with an overwhelming majority of Americans who want the Medicare Negotiation program to go further. Medicare negotiation will deliver huge savings for seniors and taxpayers; this bill would undermine that progress."
Keep ReadingShow Less
Most Popular